Growth Metrics

West Pharmaceutical Services (WST) Treasury Shares (2016 - 2026)

West Pharmaceutical Services has reported Treasury Shares over the past 18 years, most recently at $1.4 billion for Q1 2026.

  • Quarterly Treasury Shares rose 18.56% to $1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Mar 2026, up 18.56% year-over-year, with the annual reading at $1.1 billion for FY2025, 5.21% up from the prior year.
  • Treasury Shares was $4.4 million for Q1 2026 at West Pharmaceutical Services, up from $3.3 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $4.4 million in Q1 2026 and troughed at $170771.0 in Q3 2024.
  • The 5-year median for Treasury Shares is $1.3 million (2022), against an average of $1.9 million.
  • Biggest five-year swings in Treasury Shares: skyrocketed 123.51% in 2024 and later increased 5.21% in 2025.
  • Tracing WST's Treasury Shares over 5 years: stood at $370.9 million in 2022, then soared by 71.91% to $637.6 million in 2023, then surged by 65.79% to $1.1 billion in 2024, then increased by 5.21% to $1.1 billion in 2025, then rose by 24.0% to $1.4 billion in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.4 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.